Free Trial

Invesco Biotechnology & Genome ETF (PBE) Short Interest Ratio & Short Volume

$66.59 -0.08 (-0.12%)
Closing price 07/25/2025 04:10 PM Eastern
Extended Trading
$66.59 0.00 (0.00%)
As of 07/25/2025 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Invesco Biotechnology & Genome ETF Short Interest Data

Invesco Biotechnology & Genome ETF (PBE) has a short interest of 1,400 shares, representing 0.04% of the float (the number of shares available for trading by the public). This marks a 180.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 7,107 shares to cover all short positions.

Current Short Interest
1,400 shares
Previous Short Interest
500 shares
Change Vs. Previous Month
+180.00%
Dollar Volume Sold Short
$89.74 thousand
Short Interest Ratio
0.2 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
3,450,000 shares
Short Percent of Float
0.04%
Today's Trading Volume
2,428 shares
Average Trading Volume
7,107 shares
Today's Volume Vs. Average
34%
Short Selling Invesco Biotechnology & Genome ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

PBE Short Interest Over Time

PBE Days to Cover Over Time

PBE Percentage of Float Shorted Over Time

Invesco Biotechnology & Genome ETF Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20251,400 shares $89.74 thousand +180.0%0.0%0.2 $64.10
6/15/2025500 shares $31.97 thousand -50.0%0.0%0.1 $63.94
5/31/20251,000 shares $62.68 thousand -28.6%0.0%0.1 $62.68
5/15/20251,400 shares $85.18 thousand -26.3%N/A0.2 $60.84
4/30/20251,900 shares $118.33 thousand +216.7%N/A0.2 $62.28
4/15/2025600 shares $35.98 thousand -60.0%N/A0.1 $59.97
3/14/20252,100 shares $137.76 thousand +250.0%N/A0.3 $65.60
2/14/20256,700 shares $455.40 thousand +644.4%N/A1 $67.97
1/31/2025900 shares $62.42 thousand -30.8%N/A0.1 $69.36
1/15/20251,300 shares $88.76 thousand -35.0%N/A0.2 $68.28

PBE Short Interest - Frequently Asked Questions

What is Invesco Biotechnology & Genome ETF's current short interest?

Short interest is the volume of Invesco Biotechnology & Genome ETF shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 1,400 shares of PBE short. 0.04% of Invesco Biotechnology & Genome ETF's shares are currently sold short. Learn More on Invesco Biotechnology & Genome ETF's current short interest.

What is a good short interest percentage for Invesco Biotechnology & Genome ETF?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.04% of Invesco Biotechnology & Genome ETF's floating shares are currently sold short.

Is Invesco Biotechnology & Genome ETF's short interest increasing or decreasing?

Invesco Biotechnology & Genome ETF saw a increase in short interest in June. As of June 30th, there was short interest totaling 1,400 shares, an increase of 180.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Invesco Biotechnology & Genome ETF's short interest compare to its competitors?

0.04% of Invesco Biotechnology & Genome ETF's shares are currently sold short. Here is how the short interest of companies compare to Invesco Biotechnology & Genome ETF: Invesco Pharmaceuticals ETF (0.19%), SPDR S&P Health Care Equipment ETF (441.46%), SPDR S&P Pharmaceuticals ETF (4.83%), Simplify Health Care ETF (0.40%), Direxion Daily Healthcare Bull 3x Shares (4.19%), VanEck Biotech ETF (0.18%), KraneShares MSCI All China Health Care Index ETF (1.12%), Invesco Dorsey Wright Healthcare Momentum ETF (0.25%), SPDR S&P Health Care Services ETF (4.34%), ALPS Medical Breakthroughs ETF (0.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Invesco Biotechnology & Genome ETF stock?

Short selling PBE is an investing strategy that aims to generate trading profit from Invesco Biotechnology & Genome ETF as its price is falling. PBE shares are trading down $0.08 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Invesco Biotechnology & Genome ETF?

A short squeeze for Invesco Biotechnology & Genome ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PBE, which in turn drives the price of the stock up even further.

How often is Invesco Biotechnology & Genome ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PBE, twice per month. The most recent reporting period available is June, 30 2025.




This page (NYSEARCA:PBE) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners